Story
In March I will be attempting to set a new world record for ‘Everesting’ - cycling up and down a mountain cumulatively to reach a height higher than Everest. I will be ascending and descending La Croisette, on the border of France and Switzerland, over 50 times and aiming for a distance of nearly 40,000m - smashing the world record set last year of 36,500m or the equivalent of climbing Everest on a bicycle four times.
I’m taking on this huge challenge to raise funds for Blood Cancer UK, inspired by my friend and colleague David Rogers who faces his own daily challenges following a leukaemia diagnosis. David and I first met in 2008 when he offered me a job and although our career paths now mean that we live and work in different countries our friendship and shared love of cycling remain. David will attempt to do the final climb with me virtually!
David has been living with Chronic Myeloid Leukaemia since 2013. He was told at his initial diagnosis that without successful treatment he had just nine months to live. Yet here we are in 2022 and the courage and resilience that David shows on a daily basis has inspired me to take on the mountain and achieve the impossible. If by doing this I can raise awareness of CML as well as vital funds for an incredible charity every turn of the pedals will have been worth it.
If you can make a donation you’ll be helping to make a real difference to all those living with blood cancer and those yet to be diagnosed.
Thank you.
Nima
UPDATE….
Target has been reset to 38,703 which is the the new world record!
The backdrop of the Salève mountain on the French/Swiss border was the scene for a world record achievement this weekend as Nima Javaheri, from North London, completed his ride of the mountain’s iconic La Croisette climb over 50 times.
In doing so, he has conquered one of cycling’s toughest challenges and achieved a world record-breaking elevation of 40,000 metres – on a mountain that has never been Everested before thanks to its gradient and challenging descents.
Nima’s Everesting world record is all in aid of Blood Cancer UK, inspired by his friend and former colleague David Rogers, from Essex, who has been living with Chronic Myeloid Leukaemia (CML) since 2013.
Nima said: "I’ve known David for many years now and our mutual love of cycling has seen us move from former colleagues to firm friends and I know, if things were different, he’d have achieved this record with me.
"During my ride, when things were tough, the thought of David facing his daily chemo kept me going, as well as the difference this fundraising will make to others battling with blood cancer.
"The last few days have been beyond anything I’ve ever experienced before – the cold especially.
"Mentally, the first day was tough as I was riding alone but so many cyclists have joined me on the final legs – the support has been incredible."
David said: "If you were trying to describe the nicest person in the world you would be describing Nima. He’s got an inner will and power to push and achieve these sorts of feats and I’m in awe of what he’s done this week and so wished I could have been there with him.
Andy van Bergen is the founder of the cycling challenge, Everesting, in which riders complete a continuous ride of any hill or mountain until they have climbed 8,848metres – the equivalent of Mount Everest.
Andy said: "What Nima has achieved here is nothing short of incredible. He’s only the fourth person to have ever completed a quadruple Everesting and the first to have reached 50,000 metres.
"What he’s put his body through is phenomenal but I know his determination to raise as much as possible for Blood Cancer UK would have kept him going."
We're a community dedicated to beating blood cancer. We do this by funding research and supporting those affected. Since 1960, we've invested over £500 million in blood cancer research, transforming treatments and saving lives. Right now, our community is funding 360 researchers and staff across the UK who are searching for the next breakthrough. The day we will beat blood cancer is now in sight and the researchers are determined to finish the job.